Alzheimer's disease and frontotemporal dementia are devastating disorders that emerge following the buildup of misfolded proteins in the brain.

AstraZeneca & Merck announce OlympiA phase 3 trial of Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer: Rahway, New Jersey Friday, Dec ...